2-O sulfatase nucleic acid compositions

Details 2-O sulfatase nucleic acid compositions 2-O sulfatase nucleic acid compositions

2006-05-11

2008-07-08

Saidha, Tekchand (Department: 1652)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C435S196000, C435S252300, C435S320100, C536S023200

Reexamination Certificate

active

07396824

ABSTRACT:
The invention relates to 2-O sulfatase and uses thereof. In particular, the invention relates to recombinantly produced 2-O sulfatase, functional variants and nucleic acid molecules that encode these molecules. The invention also provides methods of using 2-O sulfatase for a variety of purposes, including degrading and analyzing glycosaminoglycans (GAGs) present in a sample. For instance, 2-O sulfatase may be used for determining the purity, identity, composition and sequence of glycosaminoglycans present in a sample. The invention also relates to methods of inhibiting angiogenesis and cellular proliferation as well as methods for treating cancer, neurodegenerative disease, atherosclerosis and microbial infection using 2-O sulfatase and/or GAG fragments produced by degradation with 2-O sulfatase.

REFERENCES:
patent: 5198355 (1993-03-01), Kikuchi et al.
patent: 5254801 (1993-10-01), Dotson et al.
patent: 5798239 (1998-08-01), Wilson et al.
patent: 5932211 (1999-08-01), Wilson et al.
patent: 6153188 (2000-11-01), Wilson et al.
patent: 6217863 (2001-04-01), Godavarti et al.
patent: 6597996 (2003-07-01), Venkataraman et al.
patent: 6869789 (2005-03-01), Liu et al.
patent: 6962699 (2005-11-01), Pojasek et al.
patent: 7056504 (2006-06-01), Sasisekharan et al.
patent: 7083937 (2006-08-01), Sasisekharan et al.
patent: 7105334 (2006-09-01), Pojasek et al.
patent: 7110889 (2006-09-01), Venkataraman et al.
patent: 7117100 (2006-10-01), Venkataraman et al.
patent: 7129335 (2006-10-01), Pojasek et al.
patent: 7139666 (2006-11-01), Venkataraman et al.
patent: 7150981 (2006-12-01), Habuchi et al.
patent: 7247445 (2007-07-01), Sasisekharan et al.
patent: 7270815 (2007-09-01), Sasisekharan et al.
patent: 2002/0128225 (2002-09-01), Liu et al.
patent: 2003/0008820 (2003-01-01), Kwan et al.
patent: 2003/0099628 (2003-05-01), Liu et al.
patent: 2003/0191587 (2003-10-01), Venkataraman et al.
patent: 2004/0091471 (2004-05-01), Myette et al.
patent: 2004/0092037 (2004-05-01), Sasisekharan et al.
patent: 2005/0037376 (2005-02-01), Sasisekharan et al.
patent: 2005/0214276 (2005-09-01), Myette et al.
patent: 2005/0227320 (2005-10-01), Pojasek et al.
patent: 2005/0233402 (2005-10-01), Liu et al.
patent: 2006/0024664 (2006-02-01), Sasisekharan et al.
patent: 2006/0057638 (2006-03-01), Bosques et al.
patent: 2006/0067927 (2006-03-01), Chandrasekaran et al.
patent: 2006/0067928 (2006-03-01), Liu et al.
patent: 2006/0078959 (2006-04-01), Prabhakar et al.
patent: 2006/0083711 (2006-04-01), Berry et al.
patent: 2006/0105430 (2006-05-01), Sasisekharan et al.
patent: 2006/0127950 (2006-06-01), Bosques et al.
patent: 2006/0154894 (2006-07-01), Berry et al.
patent: 2006/0177885 (2006-08-01), Myette et al.
patent: 2006/0177910 (2006-08-01), Myette et al.
patent: 2006/0177911 (2006-08-01), Myette et al.
patent: 2006/0182734 (2006-08-01), Liu et al.
patent: 2006/0183713 (2006-08-01), Liu et al.
patent: 2006/0183891 (2006-08-01), Myette et al.
patent: 2006/0292130 (2006-12-01), Sasisekharan et al.
patent: 2006/0292655 (2006-12-01), Sasisekharan et al.
patent: 2006/0292673 (2006-12-01), Sasisekharan et al.
patent: 2007/0004012 (2007-01-01), Sasisekharan et al.
patent: 2007/0020243 (2007-01-01), Sengupta et al.
patent: 2007/0065424 (2007-03-01), Pojasek et al.
patent: 2007/0065921 (2007-03-01), Sasisekharan et al.
patent: 2007/0066769 (2007-03-01), Venkataraman et al.
patent: 2007/0072268 (2007-03-01), Habuchi et al.
patent: 2007/0148157 (2007-06-01), Prabhakar et al.
patent: 2007/0148158 (2007-06-01), Sasisekharan et al.
patent: 2007/0148740 (2007-06-01), Prabhakar et al.
patent: 2007/0161073 (2007-07-01), Sasisekharan et al.
patent: 2007/0202563 (2007-08-01), Prabhakar et al.
patent: 2007/0224670 (2007-09-01), Prabhakar et al.
patent: 0355831 (1990-02-01), None
patent: 0423818 (1991-04-01), None
patent: 69006619 (1965-12-01), None
patent: WO-9716556 (1997-05-01), None
patent: WO-0026393 (2000-05-01), None
patent: WO-0121640 (2001-03-01), None
patent: WO-0218539 (2002-03-01), None
patent: WO 2002/059327 (2002-08-01), None
patent: WO 2004/031365 (2004-04-01), None
patent: WO 2005/017118 (2005-02-01), None
patent: WO-2006089206 (2006-08-01), None
patent: WO 2007/044471 (2007-04-01), None
Raman et al. [JBC (Apr. 4, 2003) vol. 278(14): 12167-74].
Myette et al. [JBC (Apr. 4, 2003) vol. 278(14): 12157-66].
Boltes et al., 1.3 A structure of arylsulfatase fromPseudomonas aeruginosaestablishes the catalytic mechanism of sulfate ester cleavage in the sulfatase family. Structure. Jun. 2001;9(6):483-91.
Bond et al., Structure of a human lysosomal sulfatase. Structure. Feb. 15, 1997;5(2):277-89.
Cohlberg et al., Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro. Biochemistry. Feb. 5, 2002;41(5):1502-11.
Folkman et al., Control of angiogenesis by heparin and other sulfated polysaccharides. Adv Exp Med Biol. 1992;313:355-64.
Higgins et al., Using CLUSTAL for multiple sequence alignments. Methods Enzymol. 1996;266:383-402.
Ishikawa et al., Inhibition of glomerular cell apoptosis by heparin. Kidney Int. Sep. 1999;56(3):954-63.
Liu et al., Cell surface heparan sulfate and its roles in assisting viral infections. Med Res Rev. Jan. 2002;22(1):1-25.
Lukatela et al., Crystal structure of human arylsulfatase A: the aldehyde function and the metal ion at the active site suggest a novel mechanism for sulfate ester hydrolysis. Biochemistry. Mar. 17, 1998;37(11):3654-64.
Nielsen et al., Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng. Jan. 1997;10(1):1-6.
Perrimon et al., Specificities of heparan sulphate proteoglycans in developmental processes. Nature. Apr. 13, 2000;404(6779):725-8.
Sehayek et al., Binding to heparan sulfate is a major event during catabolism of lipoprotein lipase by HepG2 and other cell cultures. Atherosclerosis. Apr. 7, 1995;114(1):1-8.
Vlodavsky et al., Mammalian heparanase as mediator of tumor metastasis and angiogenesis. Isr Med Assoc J. Jul. 2000;2 Suppl:37-45.
Von Bulow et al., Crystal structure of an enzyme-substrate complex provides insight into the interaction between human arylsulfatase A and its substrates during catalysis. J Mol Biol. Jan. 12, 2001;305(2):269-77.
GenBank Submission; NIH/NCBI, Accession No. AAG05721.1, AE004659—7; Stover et al.; Jul. 7, 2006.
GenBank Submission; NIH/NCBI, Accession No. AL355753; Redenbach et al.; May 12, 2002.
GenBank Submission; NIH/NCBI, Accession No. BAB38042.1; Makino et al.; May 26, 2006.
GenBank Submission; NIH/NCBI, Accession No. AAF72520.1, AF248951—1; Wright et al.; May 29, 2000.
GenBank Submission; NIH/NCBI, Accession No. AAL45442.1; Wood et al.; May 28, 2004.
GenBank Submission; NIH/NCBI, Accession No. AAL18999.1; McClelland et al.; Aug. 9, 2005.
GenBank Submission; NIH/NCBI, Accession No. CAA51272.1; Modaressi et al.; Jun. 25, 1997.
GenBank Submission; NIH/NCBI, Accession No. AAA51784.1; Peters et al.; Oct. 31, 1994.
GenBank Submission; NIH/NCBI, Accession No. AAB03341.1; Loftus et al.; Feb. 3, 2000.
GenBank Submission; NIH/NCBI, Accession No. AAG03573.1, AE004456—4; Stover et al.; Jul. 7, 2006.
GenBank Submission; NIH/NCBI, Accession No. CAA88421.2; Beilet al.; Jun. 30, 2006.
GenBank Submission; NIH/NCBI, Accession No. NP—248873.1; Stover et al.; Aug. 3, 2006.
GenBank Submission; NIH/NCBI, Accession No. P51691; Beil et al.; Sep. 19, 2006.
GenBank Submission; NIH/NCBI, Accession No. AAC51350.1; Morris et al.; Oct. 11, 2005.
GenBank Submission; NIH/NCBI, Accession No. AAA63197.1; Wilson et al.; Mar. 7, 1995.
GenBank Submission; NIH/NCBI, Accession No. AA605721; Ekker et el.; Sep. 29, 1997.
GenBank Submission; NIH/NCBI, Accession No. BAB79937; Shimizu et al.; Oct. 21, 2004.
GenBank Submission; NIH/NCBI, Accession No. AAF72520; Wright et al.; May 29, 2000.
GenBank Submission; NIH/NCBI, Accession No. AAL45441; Wood et al.; May 28, 2004.
GenBank Submission; NIH/NCBI, Accession No. AAL19003; McClelland et al.; Aug. 9, 2005.
[No Author Listed] Iduronate-2-sulfatase. Glyko Catalogue No. GAG-5009. Revised Sep. 2000.
Berteau et

Affiliated with

Also associated with

Rating

2-O sulfatase nucleic acid compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-O sulfatase nucleic acid compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-O sulfatase nucleic acid compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3972693